CIK 0001404644
- Non-accelerated filer
- Smaller reporting company
Neurogene Inc.
Sign in to watch- Ticker
- NGNE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 980542593
- Phone
- +1 877-237-5020
- Business address
- 535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
- Former names
- Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 38 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-20 | BAKER BROS. ADVISORS LP Director | Grant or award · Pre-funded Warrants | +9,765,333 | 9,765,333 | ||
| 2019-12-20 | DRACHMAN JONATHAN G President and CEO | Purchase | +119,047 | $8.40 | $1000K | 2,198,686 |
| 2019-11-12 | DRACHMAN JONATHAN G President and CEO | Conversion | −12,616 | 0 | ||
| 2019-11-12 | DRACHMAN JONATHAN G President and CEO | Conversion | +1,261,600 | 2,079,639 | ||
| 2019-10-10 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2019-10-10 | SIMPSON TODD E Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2019-10-10 | Noonberg Sarah B. Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2019-10-10 | Nolan Sean P. Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2019-10-10 | Williams Lewis T Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2019-09-11 | DRACHMAN JONATHAN G See Remarks | Purchase | +136,436 | $3.30 | $450K | 584,428 |
| 2019-09-10 | DRACHMAN JONATHAN G See Remarks | Purchase | +36,742 | $3.08 | $113K | 447,992 |
| 2019-09-09 | DRACHMAN JONATHAN G See Remarks | Purchase | +76,822 | $2.85 | $219K | 411,250 |
| 2019-08-31 | DRACHMAN JONATHAN G See Remarks | Grant or award · Stock Option (Right to Buy) | +1,650,000 | 1,650,000 | ||
| 2019-08-08 | DRACHMAN JONATHAN G See Remarks | Grant or award | +568,039 | 568,039 | ||
| 2019-08-08 | DRACHMAN JONATHAN G See Remarks | Grant or award | +12,616 | 12,616 | ||
| 2019-08-08 | DRACHMAN JONATHAN G President and CEO | Grant or award | +334,428 | 334,428 | ||
| 2019-08-08 | DRACHMAN JONATHAN G President and CEO | Grant or award | +7,428 | 7,428 | ||
| 2019-08-07 | BAKER BROS. ADVISORS LP Director | Purchase | +531 | $2.96 | $2K | 1,177,013 |
| 2019-08-07 | BAKER BROS. ADVISORS LP Director | Purchase | +5,869 | $2.96 | $17K | 9,845,341 |
| 2019-08-07 | BAKER BROS. ADVISORS LP Director | Purchase | +18,943 | $3.02 | $57K | 1,195,956 |
Page 12 of 20 · 397 trades